Publications

Publications2020-11-05T04:24:51+00:00

Latest publication from Science Translational Medicine 2020

Science Translation Medicine
2019

Neurosurgery. 2019 May 09; 85(4)

Phase 1 safety, pharmacokinetics, and fluorescence imaging study of tozuleristide (BLZ-100) in adults with newly diagnosed or recurrent gliomas

2019

Adv Pharm Bull. 2019; 9(4)

Current biochemical applications and future prospects of chlorotoxin in cancer diagnostics and therapeutics

2016

J Clin Neurosci. 2016 Jul 21; 33

Glioblastoma multiforme targeted therapy: The chlorotoxin story

2015

Curr Top Med Chem. 2015 Apr 11; 15(13)

Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma

2015

Toxins. 2015 Mar 27; 7(4)

Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion

2014

Am J Nucl Med Mol Ima. 2014 Aug 15; 4(5)

Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates

2012

Biotechnol Bioeng. 2012 Nov 01; 110(4)

Targeted nitric oxide delivery preferentially induces glioma cell chemosensitivity via altered p53 and O(6) -methylguanine-DNA methyltransferase activity

2012

Cancer J. 2012 Jan-Feb; 18(1)

Outside the box–novel therapeutic strategies for glioblastoma

2011

J Neurooncol. 2011 Nov 23; 107(3)

Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs

2008

Exp Biol and Med. 2008 Jul 01; 233(7)

An unexpected role for ion channels in brain tumor metastasis

2008

J Nucl Med. 2008 May 01; 49(1)

Intravenous I-131 Chlorotoxin (TM601): Imaging and pharmacokinetic analysis in patients with primary malignant glioma or cerebral metastatic solid tumors

2007

Int J of Radiation Onco Bio Phy. 2007 Sep 27; 69 (3)

Tumor Specific Targeting of Intravenous 131I-chlorotoxin (TM-601) in Patients With Recurrent Glioma

2007

Expert Opin Drug Deliv. 2007 Mar 05; 4(2)

Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)

2006

J of Clin Oncology. 2006 Aug 1; 24(22)

Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma

2006

J of Clin Oncology. 2006 Jun 20; 24(18)

Safety and tolerance of multiple weekly intracavitary injections of 131I-chlorotoxin (TM-601): Preliminary results of a prospective clinical trial in patients with recurrent glioblastoma multiforme

2006

Neuron Glia Biol. 2006 Feb; 2(1)

A role for ion channels in glioma cell invasion

2005

Cancer Res. 2005 May; 65(9)

Chlorotoxin, a small peptide derived from scorpion venom, targets cancer cells via a phosphatidylinositol phosphate

2005

J Nucl Med. 2005 Apr; 46(4)

Imaging glioma extent with 131I-TM-601

2004

Curr Treat Options Oncol. 2004 Dec; 5(6)

Targeted molecular therapy for malignant gliomas

2004

Neuron Glia Biol. 2006 Feb; 2(1)

A role for ion channels in glioma cell invasion